Risk of arterial thromboembolic events* before cancer diagnosis
Time before cancer . | Cancer patients . | Cancer-free controls . | . | . |
---|---|---|---|---|
diagnosis, d . | Events, no. (%) . | Events, no. (%) . | OR (95% CI) . | P . |
1-30 | 2313 (0.62) | 413 (0.11) | 5.63 (5.07-6.25) | <.001 |
31-60 | 635 (0.17) | 365 (0.10) | 1.74 (1.53-1.98) | <.001 |
61-90 | 496 (0.13) | 315 (0.08) | 1.58 (1.37-1.81) | <.001 |
91-120 | 431 (0.12) | 349 (0.09) | 1.24 (1.07-1.42) | .003 |
121-150 | 427 (0.11) | 342 (0.09) | 1.25 (1.08-1.44) | .002 |
151-180 | 379 (0.10) | 333 (0.09) | 1.14 (0.98-1.32) | .08 |
181-210 | 312 (0.08) | 291 (0.08) | 1.07 (0.91-1.26) | .39 |
211-240 | 370 (0.10) | 318 (0.08) | 1.17 (1.00-1.35) | .05 |
241-270 | 309 (0.08) | 306 (0.08) | 1.01 (0.86-1.18) | .90 |
271-300 | 316 (0.08) | 311 (0.08) | 1.02 (0.87-1.19) | .84 |
301-330 | 334 (0.09) | 313 (0.08) | 1.07 (0.92-1.25) | .41 |
331-360 | 317 (0.08) | 300 (0.08) | 1.06 (0.90-1.24) | .49 |
Time before cancer . | Cancer patients . | Cancer-free controls . | . | . |
---|---|---|---|---|
diagnosis, d . | Events, no. (%) . | Events, no. (%) . | OR (95% CI) . | P . |
1-30 | 2313 (0.62) | 413 (0.11) | 5.63 (5.07-6.25) | <.001 |
31-60 | 635 (0.17) | 365 (0.10) | 1.74 (1.53-1.98) | <.001 |
61-90 | 496 (0.13) | 315 (0.08) | 1.58 (1.37-1.81) | <.001 |
91-120 | 431 (0.12) | 349 (0.09) | 1.24 (1.07-1.42) | .003 |
121-150 | 427 (0.11) | 342 (0.09) | 1.25 (1.08-1.44) | .002 |
151-180 | 379 (0.10) | 333 (0.09) | 1.14 (0.98-1.32) | .08 |
181-210 | 312 (0.08) | 291 (0.08) | 1.07 (0.91-1.26) | .39 |
211-240 | 370 (0.10) | 318 (0.08) | 1.17 (1.00-1.35) | .05 |
241-270 | 309 (0.08) | 306 (0.08) | 1.01 (0.86-1.18) | .90 |
271-300 | 316 (0.08) | 311 (0.08) | 1.02 (0.87-1.19) | .84 |
301-330 | 334 (0.09) | 313 (0.08) | 1.07 (0.92-1.25) | .41 |
331-360 | 317 (0.08) | 300 (0.08) | 1.06 (0.90-1.24) | .49 |
Composite of myocardial infarction and ischemic stroke diagnoses.